NCT01876368 - Efficacy and Safety of LCZ696 Compared to Olmesartan in Essential Hypertensive Patients Not Responsive to Olmesartan | Biotech Hunter

Enrollment

376

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions

Hypertension

Interventions

DRUG

LCZ696

DRUG

Olmesartan

DRUG

Placebo of LCZ696

DRUG

Placebo of Olmesartan

Trial Locations (51)

1000

Novartis Investigative Site, Manila

1100

Novartis Investigative Site, Quezon City

1102

Novartis Investigative Site, Quezon City

10708

Novartis Investigative Site, New York

15706

Novartis Investigative Site, Santiago de Compostela

23294

Novartis Investigative Site, Richmond

28046

Novartis Investigative Site, Madrid

29944

Novartis Investigative Site, Varnville

30094

Novartis Investigative Site, Conyers

30308

Novartis Investigative Site, Atlanta

39038

Novartis Investigative Site, Belzoni

39209

Novartis Investigative Site, Jackson

41009

Novartis Investigative Site, Seville

45246

Novartis Investigative Site, Cincinnati

46600

Novartis Investigative Site, Alzira

55435

Novartis Investigative Site, Edina

60607

Novartis Investigative Site, Chicago

60610

Novartis Investigative Site, Chicago

66606

Novartis Investigative Site, Topeka

80206

Novartis Investigative Site, Denver

90057

Novartis Investigative Site, Los Angeles

90716

Novartis Investigative Site, Hawaiian Gardens

90806

Novartis Investigative Site, Long Beach

91361

Novartis Investigative Site, Westlake Village

95628

Novartis Investigative Site, Fair Oaks

95662

Novartis Investigative Site, Orangevale

97045

Novartis Investigative Site, Oregon City

97225

Novartis Investigative Site, Portland

101990

Novartis Investigative Site, Moscow

111539

Novartis Investigative Site, Moscow

117198

Novartis Investigative Site, Moscow

129301

Novartis Investigative Site, Moscow

197110

Novartis Investigative Site, Saint Petersburg

199106

Novartis Investigative Site, Saint Petersburg

410012

Novartis Investigative Site, Saratov

35294-2041

Novartis Investigative Site, Birmingham

C1120AAC

Novartis Investigative Site, Buenos Aires

C1429BWN

Novartis Investigative Site, Caba

C1119ACN

Novartis Investigative Site, Ciudad Autonoma de Bs As

C1430AAQ

Novartis Investigative Site, Ciudad Autonoma de Bs As

C1425FVH

Novartis Investigative Site, Caba

W3400

Novartis Investigative Site, Corrientes

N3300AHX

Novartis Investigative Site, Posadas

01001

Novartis Investigative Site, Guatemala City

01010

Novartis Investigative Site, Guatemala City

00674

Novartis Investigative Site, Manatí

00716

Novartis Investigative Site, Ponce

00717

Novartis Investigative Site, Ponce

08540

Novartis Investigative Site, Centelles

08550

Novartis Investigative Site, Hostalets de Balenya